Skip to content
Home/Companies/Biotech/ArkVax
ArkVax

ArkVax

Biotech·UK·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns ArkVax?

ArkVax is currently owned by Future Planet Capital through UK Innovation and Science Seed Fund (2012 vintage), since 2022.

Hand-verified · updated 2026-08-04

Future Planet Capital
Investor
Future Planet Capital
UK Innovation and Science Seed Fund · 2012 · VC

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.arkvax.com

More from UK Innovation and Science Seed Fund

Other portfolio companies in the same fund.

52North Health
52North Health
Active
HealthTechUK
Akrivia Health
Akrivia Health
Active
HealthTechUK
Antiverse
Antiverse
Active
BiotechUK
CellCentric
CellCentric
Active
BiotechUK
Clare Sys
Clare Sys
Active
Deep TechUK
Crescendo Biologics
Crescendo Biologics
Active
BiotechUK

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Inits Group
Inits Group
Active
Sofilaro GestionFrance
Isavy Biotech
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Track ArkVax

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on ArkVax.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue